semaglutide not for human consumption Research Material | GLP-1 Collection Semaglutide 10mg, 20mg, 30mg |

These real-world results corroborate the findings from clinical trials and demonstrate the practical benefits of GLP-1 injections for weight management in diverse patient populations

In ATTAIN-2 , which specifically studied people with both obesity and type 2 diabetes (a group for whom weight loss is known to be harder), participants on the highest dose lost an average of 10.5% of body weight (about 23 lbs) over 72 weeks, while also reducing A1C by an average of 1.8%

linagliptin needs no renal adjustment Limitations & safety Cardiovascular outcome trials (CVOTs) PBS rules (Authority Required Streamlined) Must be used with metformin sulfonylurea and/or insulin

Cost Uncertainty Retatrutide does not have an established retail price since it has not been approved